ANNAPOLIS, Md. (PRWEB) November 02, 2018
Pulse8 Inc., a leading healthcare analytics company focused on Risk Adjustment, Quality, and Pharmacy for the ACA Commercial, Medicare Advantage, and Medicaid markets, is pleased to announce the promotion of two company veterans, Mark Brooks and Courtney Yeakel.
Mark will serve as Pulse8’s Chief Financial Officer and Courtney will serve as the Chief Product Officer. Both of these newly-created executive roles have been made necessary by Pulse8’s abundant growth – in terms of its number of customers, employees, and products.
Mark will be responsible for the management and execution of the finance, accounting, and administrative functions at Pulse8, a position ideal for a CPA with an MBA degree. Adding to Mark’s impressive credentials and business perspective are his three years as Pulse8’s VP of Product Strategy and dozen years of health plan experience. Having joined Pulse8 in 2015, Mark brought a myriad of insight from the health plan’s perspective, which helped him to successfully manage Pulse8’s team of data scientists, researchers, and risk adjustment experts, in developing the most advanced analytics and data products the industry has to offer.
“We are thrilled to transition Mark into this role for which he excels so naturally and effectively. There is no better Pulse8 veteran to handle all financial aspects and lead our corporate strategy,” said Mr. John Criswell, Chief Executive Officer at Pulse8.
Courtney is an industry veteran and established Pulse8 leader with a lengthy history of proven success dating back to her prior tenure with a large ACA/Medicare/Medicaid health plan. Also joining Pulse8 in 2015, Courtney has spent the last three years as Pulse8’s VP of Customer Engagement, overseeing the end-to-end delivery of Pulse8’s comprehensive product portfolio into Pulse8’s rapidly expanding customer base and ensuring the effective utilization of those products so that our customers generate the best possible outcomes.
“Courtney is truly a results-driven leader with a fantastic track record of success throughout her career and for Pulse8 as well,” states John Criswell. “Her industry background and full understanding of the customer’s needs have contributed to her being the optimal choice for this position. We are more than confident that she will take our sophisticated and unmatched suite of products to the next level to ensure that Pulse8 continues to lead the market for Risk Adjustment, Quality, and Pharmacy Program Management solutions.”
Pulse8 is the only Healthcare Analytics and Technology Company delivering complete visibility into the efficacy of your Risk Adjustment, Quality, and Pharmacy Benefit Management programs. We enable health plans and providers to eliminate waste and achieve the greatest financial impact in the Medicare Advantage, Medicaid, and ACA Commercial markets as well as with Value-Based Payment models for Medicare. Our advanced analytic methodologies and flexible business intelligence tools offer real-time visibility into member behavior and provider performance. Pulse8’s Illumin8 Active Intelligence™ platform offers a suite of uniquely pragmatic solutions that are powered by our patent-pending Dynamic Intervention Planning to deliver the most cost-effective and appropriate interventions for closing gaps in documentation, coding, and quality. For more company information or to schedule a demo, please contact Scott Filiault at (732) 570-9095 or email@example.com.